Integrum named to Fast Company’s 2023 List of the World’s Most Innovative Companies
Mölndal, Sweden – March 2nd 2023 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies for 2023.
According to Fast Company, this year’s list highlights businesses at the forefront of their respective industries, paving the way for the innovations of tomorrow. Integrum is named among companies that have set the standard with some of the greatest accomplishments of the modern world.
“There are more than 2 million amputees in the U.S. alone and nearly 185,000 new amputations are performed every year across the country. Because of our OPRA Implant System, individuals who have or need above-knee amputation have the opportunity to be relieved from unnecessary pain and frustration, connect their body and mind and help them live life to the fullest,” said Rickard Brånemark, MD, PhD, orthopedic surgeon and founder of Integrum.
In 1990, the first iteration of the OPRA Implant System was implanted in a bilateral transfemoral patient in Sweden. Developed and refined since then, the OPRA Implant System is the only FDA-approved bone-anchored implant system specifically designed for use in amputees in the U.S. It is indicated for individuals who have undergone transfemoral, or above-knee, amputations, and who have, or are anticipated to have, rehabilitation problems with, or cannot use, a conventional socket prosthesis. The OPRA Implant System provides increased mobility, stability, enhanced comfort, and a reduction in pressure, chafing, skin breakdown, and pain. Read about people whose lives have been transformed with the OPRA Implant System here: https://integrum.se/stories/
“Integrum has been leading the development of bone-anchored orthopedic technology for over 30 years and is facing our most expansive phase to date as we continue to build upon vital partnerships with leading academic hospitals, clinicians, and our commercial partners based upon peer-reviewed clinical and cost-effectiveness studies for our revolutionary OPRA Implant System. We are thrilled to be recognized by Fast Company for our longstanding mission and dedication to improving the quality of life for amputees everywhere and look forward to the next 30 years of changing lives,” said Thomas Dugan, president of Integrum, Inc. “”
Fast Company will host its third annual Most Innovative Companies Summit on April 19 and 20. The virtual summit celebrates the Most Innovative Companies in business, and provides an inside look at cutting-edge business trends and what it takes to innovate in 2023. Fast Company’s Most Innovative Companies issue (March/April 2023) is available online here, as well as in app form via iTunes, and on newsstands beginning March 14.
For more information please contact:
Rickard Brånemark, CEO. Phone: +46 708 461061, E-mail: rickard.branemark@integrum.se
Dennis Baecklund, CFO. Phone: +46 725 566869, E-mail: dennis.baecklund@integrum.se
Certified Adviser
Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.
ABOUT INTEGRUM
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA™ Implant System has helped improve the quality of life for hundreds of people who are amputees by directly attaching a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA™ System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use in amputees available in the U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/.
ABOUT FAST COMPANY
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC and our sister publication Inc., and can be found online at www.fastcompany.com.